Attenuon builds patent portfolio for cancer therapeutics
Client(s) Attenuon, L.L.C.
Jones Day represented Attenuon, L.L.C. regarding its patent portfolio relating to cancer therapeutics.
Client(s) Attenuon, L.L.C.
Jones Day represented Attenuon, L.L.C. regarding its patent portfolio relating to cancer therapeutics.